Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-14 12:36 pm Purchase | 2024-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 1,015,023 5.400% | 5,929![]() (+0.59%) | Filing History |
2025-02-05 1:23 pm Sale | 2024-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | BlackRock Inc. BLK | 2,945,939 15.600% | -16,155![]() (-0.55%) | Filing History |
2024-11-14 3:19 pm Sale | 2024-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 1,009,094 5.500% | -334,060![]() (-24.87%) | Filing History |
2024-11-08 5:34 pm Sale | 2024-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND | GOLDMAN SACHS GROUP INC GS | 52,350 0.300% | -1,129,581![]() (-95.57%) | Filing History |
2024-11-01 4:07 pm Sale | 2024-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND | MACQUARIE GROUP LTD | 887,275 4.860% | -99,973![]() (-10.13%) | Filing History |
2024-02-14 06:26 am Sale | 2023-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | MACQUARIE GROUP LTD | 987,248 5.660% | -14,577![]() (-1.46%) | Filing History |
2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | Ligand Pharmaceuticals Incorporated LGND | VANGUARD GROUP INC | 1,876,514 10.760% | 33,399![]() (+1.81%) | Filing History |
2024-02-13 3:39 pm Purchase | 2023-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 1,343,154 7.700% | 87,881![]() (+7.00%) | Filing History |
2024-02-12 7:42 pm Purchase | 2023-12-29 | 13G | Ligand Pharmaceuticals Incorporated LGND | GOLDMAN SACHS GROUP INC GS | 1,181,931 6.800% | 1,181,931![]() (New Position) | Filing History |
2024-01-22 2:03 pm Purchase | 2023-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | BlackRock Inc. BLK | 2,962,094 17.000% | 172,615![]() (+6.19%) | Filing History |
2023-03-30 4:08 pm Sale | 2023-03-28 | 13D | Viking Therapeutics, Inc. VKTX | LIGAND PHARMACEUTICALS INC LGND | 3,616,077 4.600% | -2,449,003![]() (-40.38%) | Filing History |
2023-02-10 3:23 pm Sale | 2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 1,255,273 7.400% | -1,054,786![]() (-45.66%) | Filing History |
2023-02-09 4:30 pm Sale | 2023-02-06 | 13D | Viking Therapeutics, Inc. VKTX | LIGAND PHARMACEUTICALS INC LGND | 6,065,080 7.900% | -1,274,303![]() (-17.36%) | Filing History |
2023-02-09 1:53 pm Sale | 2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 141,128 0.800% | -2,103,619![]() (-93.71%) | Filing History |
2023-02-09 11:25 am Sale | 2022-12-30 | 13G | Ligand Pharmaceuticals Incorporated LGND | VANGUARD GROUP INC | 1,843,115 10.910% | -908,811![]() (-33.02%) | Filing History |
2023-02-06 3:18 pm Sale | 2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | STATE STREET CORP STT | 649,914 3.850% | -772,513![]() (-54.31%) | Filing History |
2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | BlackRock Inc. BLK | 2,789,479 16.500% | 0 (Unchanged) | Filing History |
2023-01-20 5:17 pm Sale | 2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | BlackRock Inc. BLK | 2,789,479 16.500% | -1,607,242![]() (-36.56%) | Filing History |
2022-02-14 10:39 am Sale | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | MACQUARIE GROUP LTD | 1,001,825 3.740% | -462,760![]() (-31.60%) | Filing History |
2022-02-11 6:20 pm Sale | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | CARDINAL CAPITAL MANAGEMENT LLC | 260,661 1.000% | -1,483,828![]() (-85.06%) | Filing History |